Company Filing History:
1 out of 832,891 Years Active: 2024
Title: Yashi Dhawan: Innovator in Upper Respiratory Infection Treatments
Introduction
Yashi Dhawan is a notable inventor based in Lucknow, India. He has made significant contributions to the field of medical formulations, particularly in the treatment of upper respiratory infections. His innovative approach combines various compounds to enhance the effectiveness of treatments for viral infections.
Latest Patents
Yashi Dhawan holds a patent for the formulation of ear drops and methods for delivery thereof for treating upper respiratory infections. This patent, which is focused on compound formulations and methods for preventing or treating upper respiratory virus infections, such as influenza, respiratory syncytial virus (RSV), SARS, and SARS-COV-2, showcases his commitment to advancing medical science. The compounds he developed may exhibit antiviral, antimicrobial, anti-inflammatory, or cytoprotective activities. The liquid formulations can be administered into the outer canal of the ear, allowing for effective delivery to the nasal and oral cavities, nasopharynx, posterior pharynx, and laryngopharynx. These areas are primary sites for upper respiratory infections, and his methods facilitate the trans-tympanic membrane translocation of the compounds through various techniques.
Career Highlights
Yashi Dhawan's career is marked by his dedication to research and innovation in the medical field. His work has the potential to significantly impact the treatment of upper respiratory infections, providing new avenues for effective therapies. His patent reflects a deep understanding of both the scientific and practical aspects of medical treatment.
Collaborations
Yashi Dhawan collaborates with Subhash Dhawan, contributing to the development and refinement of his innovative formulations. Their partnership exemplifies the importance of teamwork in advancing medical research and innovation.
Conclusion
Yashi Dhawan is a pioneering inventor whose work in formulating treatments for upper respiratory infections is noteworthy. His patent demonstrates a significant advancement in medical science, with the potential to improve health outcomes for many individuals.